325 related articles for article (PubMed ID: 12476542)
21. Loratadine and montelukast administered in combination produce decongestion in an experimental feline model of nasal congestion.
McLeod RL; Mingo GG; Xu X; Palamanda J; Hunter JC; Jia Y
Am J Rhinol Allergy; 2009; 23(6):e17-22. PubMed ID: 19769798
[TBL] [Abstract][Full Text] [Related]
22. 24-hour efficacy of once-daily desloratadine therapy in patients with seasonal allergic rhinitis [ISRCTN32042139].
Salmun LM; Lorber R
BMC Fam Pract; 2002 Aug; 3():14. PubMed ID: 12162793
[TBL] [Abstract][Full Text] [Related]
23. Levocetirizine improves nasal obstruction and modulates cytokine pattern in patients with seasonal allergic rhinitis: a pilot study.
Ciprandi G; Cirillo I; Vizzaccaro A; Tosca MA
Clin Exp Allergy; 2004 Jun; 34(6):958-64. PubMed ID: 15196286
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of fixed-dose loratadine/montelukast in seasonal allergic rhinitis: effects on nasal congestion.
Prenner B; Anolik R; Danzig M; Yao R
Allergy Asthma Proc; 2009; 30(3):263-9. PubMed ID: 19549427
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the effects of desloratadine 5-mg daily and placebo on nasal airflow and seasonal allergic rhinitis symptoms induced by grass pollen exposure.
Horak F; Stübner P; Zieglmeyer R; Harris AG
Allergy; 2003 Jun; 58(6):481-5. PubMed ID: 12757447
[TBL] [Abstract][Full Text] [Related]
26. Impact and modulation of nasal obstruction.
Horak F
Allergy; 2002; 57 Suppl 75():25-8. PubMed ID: 12492726
[TBL] [Abstract][Full Text] [Related]
27. Comparative study of SCH 434 and CTM-D in the treatment of seasonal allergic rhinitis.
Prevost M; Turenne Y; Moote DW; Mazza J; Clermont A; PetitClerc C; Danzig MR
Clin Ther; 1994; 16(1):50-6. PubMed ID: 7911402
[TBL] [Abstract][Full Text] [Related]
28. Azelastine nasal spray and desloratadine tablets in pollen-induced seasonal allergic rhinitis: a pharmacodynamic study of onset of action and efficacy.
Horak F; Zieglmayer UP; Zieglmayer R; Kavina A; Marschall K; Munzel U; Petzold U
Curr Med Res Opin; 2006 Jan; 22(1):151-7. PubMed ID: 16393441
[TBL] [Abstract][Full Text] [Related]
29. Decongestant efficacy of desloratadine in patients with seasonal allergic rhinitis.
Bachert C
Allergy; 2001; 56 Suppl 65():14-20. PubMed ID: 11243500
[TBL] [Abstract][Full Text] [Related]
30. SCH 434: a new antihistamine/decongestant for seasonal allergic rhinitis.
Storms WW; Bodman SF; Nathan RA; Chervinsky P; Banov CH; Dockhorn RJ; Jarmoszuk I; Zeitz HJ; McGeady SJ; Pinnas JL
J Allergy Clin Immunol; 1989 Jun; 83(6):1083-90. PubMed ID: 2471718
[TBL] [Abstract][Full Text] [Related]
31. Safety and efficacy of desloratadine in subjects with seasonal allergic rhinitis or chronic urticaria: results of four postmarketing surveillance studies.
Bachert C; Maurer M
Clin Drug Investig; 2010; 30(2):109-22. PubMed ID: 20067329
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis.
Van Cauwenberge P; Juniper EF
Clin Exp Allergy; 2000 Jun; 30(6):891-9. PubMed ID: 10848909
[TBL] [Abstract][Full Text] [Related]
33. Comparative efficacy and safety of once-daily versus twice-daily loratadine-pseudoephedrine combinations versus placebo in seasonal allergic rhinitis.
Kaiser HB; Banov CH; Berkowitz RR; Bernstein DI; Bronsky EA; Georgitis JW; Mendelson LM; Rooklin AR; Sholler LJ; Stricker WW; Harrison JE; Danzig MR; Lorber RR
Am J Ther; 1998 Jul; 5(4):245-51. PubMed ID: 10099066
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of azelastine nasal spray in patients with an unsatisfactory response to loratadine.
Berger WE; White MV;
Ann Allergy Asthma Immunol; 2003 Aug; 91(2):205-11. PubMed ID: 12952117
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of acrivastine plus pseudoephedrine for symptomatic relief of seasonal allergic rhinitis due to mountain cedar.
Williams BO; Hull H; McSorley P; Frosolono MF; Sanders RL
Ann Allergy Asthma Immunol; 1996 May; 76(5):432-8. PubMed ID: 8630717
[TBL] [Abstract][Full Text] [Related]
36. [Nasal budesonide plus zafirlukast vs nasal budesonide plus loratadine-pseudoephedrine for controlling the symptoms of rhinitis and asthma].
Benitez HH; Arvizu VM; Gutiérrez DJ; Fogelbach GA; Castellanos Olivares A; Vázquez Nava F; Velázquez HC; González Pérez Mdel C; Mora Nieto A; Rodríguez EC
Rev Alerg Mex; 2005; 52(2):90-5. PubMed ID: 16158782
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of an oral formulation of cetirizine and prolonged-release pseudoephedrine versus xylometazoline nasal spray in nasal congestion.
Stübner UP; Toth J; Marks B; Berger UE; Burtin B; Horak F
Arzneimittelforschung; 2001 Nov; 51(11):904-10. PubMed ID: 11765592
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of desloratadine, 5 mg, compared with fexofenadine, 180 mg, in patients with symptomatic seasonal allergic rhinitis.
Berger WE; Lumry WR; Meltzer EO; Pearlman DS
Allergy Asthma Proc; 2006; 27(3):214-23. PubMed ID: 16913264
[TBL] [Abstract][Full Text] [Related]
39. Desloratadine activity in concurrent seasonal allergic rhinitis and asthma.
Baena-Cagnani CE
Allergy; 2001; 56 Suppl 65():21-7. PubMed ID: 11243501
[TBL] [Abstract][Full Text] [Related]
40. Effects of fexofenadine and desloratadine on subjective and objective measures of nasal congestion in seasonal allergic rhinitis.
Wilson AM; Haggart K; Sims EJ; Lipworth BJ
Clin Exp Allergy; 2002 Oct; 32(10):1504-9. PubMed ID: 12372132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
